Literature DB >> 33499244

The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD.

Rona Harari-Steinfeld1, Maytal Gefen1, Alina Simerzin1, Elina Zorde-Khvalevsky1, Mila Rivkin1, Ezra Ella1, Tomer Friehmann1, Mordechay Gerlic2, Jessica Zucman-Rossi3,4, Stefano Caruso3, Mélissa Leveille5, Jennifer L Estall5, Daniel S Goldenberg1, Hilla Giladi1, Eithan Galun1, Zohar Bromberg1.   

Abstract

The H19-derived microRNA-675 (miR-675) has been implicated as both tumor promoter and tumor suppressor and also plays a role in liver inflammation. We found that miR-675 promotes cell death in human hepatocellular carcinoma (HCC) cell lines. We show that Fas-associated protein with death domain (FADD), a mediator of apoptotic cell death signaling, is downregulated by miR-675 and a negative correlation exists between miR-675 and FADD expression in mouse models of HCC (p = 0.014) as well as in human samples (p = 0.017). We demonstrate in a mouse model of liver inflammation that overexpression of miR-675 promotes necroptosis, which can be inhibited by the necroptosis-specific inhibitor Nec-1/Nec-1s. miR-675 induces the level of both p-MLKL (Mixed Lineage Kinase Domain-Like Pseudokinase) and RIP3 (receptor-interacting protein 3), which are key signaling molecules in necroptosis, and enhances MLKL binding to RIP3. miR-675 also inhibits the levels of cleaved caspases 8 and 3, suggesting that miR-675 induces a shift from apoptosis to a necroptotic cellular pathway. In conclusion, downregulation of FADD by miR-675 promotes liver necroptosis in response to inflammatory signals. We propose that this regulation cascade can stimulate and enhance the inflammatory response in the liver, making miR-675 an important regulator in liver inflammation and potentially also in HCC.

Entities:  

Keywords:  apoptosis; hepatocellular carcinoma; liver inflammation; necrosis

Year:  2021        PMID: 33499244      PMCID: PMC7866230          DOI: 10.3390/cancers13030411

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  47 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

2.  The oncofetal H19 RNA connection: hypoxia, p53 and cancer.

Authors:  Imad J Matouk; Shaul Mezan; Aya Mizrahi; Patricia Ohana; Rasha Abu-Lail; Yakov Fellig; Nathan Degroot; Eithan Galun; Abraham Hochberg
Journal:  Biochim Biophys Acta       Date:  2010-02-01

3.  Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors.

Authors:  P Génin; M Algarté; P Roof; R Lin; J Hiscott
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

Review 4.  The roles of FADD in extrinsic apoptosis and necroptosis.

Authors:  Eun-Woo Lee; Jinho Seo; Manhyung Jeong; Sangsik Lee; Jaewhan Song
Journal:  BMB Rep       Date:  2012-09       Impact factor: 4.778

Review 5.  Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.

Authors:  Daniel Lin; Jennifer Wu
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.

Authors:  Lika Gamaev; Lina Mizrahi; Tomer Friehmann; Nofar Rosenberg; Orit Pappo; Devorah Olam; Evelyne Zeira; Keren Bahar Halpern; Stefano Caruso; Jessica Zucman-Rossi; Jonathan H Axelrod; Eithan Galun; Daniel S Goldenberg
Journal:  Oncogene       Date:  2020-10-22       Impact factor: 9.867

Review 7.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

8.  The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r.

Authors:  Andrew Keniry; David Oxley; Paul Monnier; Michael Kyba; Luisa Dandolo; Guillaume Smits; Wolf Reik
Journal:  Nat Cell Biol       Date:  2012-06-10       Impact factor: 28.824

9.  miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.

Authors:  Haiyan Li; Jiao Li; Song Jia; Mengying Wu; Jiahui An; Qidi Zheng; Wei Zhang; Dongdong Lu
Journal:  Oncotarget       Date:  2015-10-13

10.  Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis.

Authors:  Kathrin Weber; Ria Roelandt; Inge Bruggeman; Yann Estornes; Peter Vandenabeele
Journal:  Commun Biol       Date:  2018-01-22
View more
  6 in total

Review 1.  The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Authors:  Leonid N Maslov; Sergey V Popov; Natalia V Naryzhnaya; Alexandr V Mukhomedzyanov; Boris K Kurbatov; Ivan A Derkachev; Alla A Boshchenko; Igor Khaliulin; N Rajendra Prasad; Nirmal Singh; Alexei Degterev; Evgenia A Tomilova; Ekaterina V Sapozhenkova
Journal:  Apoptosis       Date:  2022-08-20       Impact factor: 5.561

2.  Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.

Authors:  Cong Chen; Yumeng Wu; Kang Chen; Zicong Xia; Xiaokan Liu; Chaojie Zhang; Hui Zhao; Aiguo Shen
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

3.  Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.

Authors:  Jun Gu; Zexi He; Yinglong Huang; Ting Luan; Zhenjie Chen; Jiansong Wang; Mingxia Ding
Journal:  Dis Markers       Date:  2022-05-23       Impact factor: 3.464

4.  Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs.

Authors:  Xiayao Diao; Chao Guo; Shanqing Li
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

5.  A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma.

Authors:  Pengfei Xia; Yimin Huang; Gang Chen
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

6.  Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma.

Authors:  Jiantao Mo; Zhiwei Cui; Qiqi Wang; Weifan Zhang; Jie Li; Shuai Wu; Weikun Qian; Cancan Zhou; Qingyong Ma; Zheng Wang; Zheng Wu
Journal:  Front Genet       Date:  2022-08-16       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.